ABCG2 and cancer: In a study by Hirschmann-Jax et al. (2004) primary NB tumor cells showed an elevated expression of ABC transporters including ABCG2, which are responsible for the efflux of therapeutic drugs and therefore for the resistance and survival of these cancer cells.